Clinical Trials Insight: 700027231

Trial Profile

Clinical Trials Insight: 700027231

Phase of Trial: Phase II

Latest Information Update: 21 May 2008

At a glance

  • Drugs Iroxanadine (Primary)
  • Indications Diabetic foot ulcer
  • Focus Therapeutic Use
  • Sponsors CytRx Corporation
  • Most Recent Events

    • 21 May 2008 The planned start for this trial is now the first quarter of 2009, according to a CytRx media release.
    • 23 Jan 2008 The planned start for this trial has been moved to the second half of 2008, according to a CytRx Corporation media release, to allow for the development of a manufacturing process.
    • 01 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top